Childhood Asthma and Second-Hand Cannabis Smoke

By Chuck Dinerstein, MD, MBA — Jan 18, 2023
Asthma is a significant disease; among children, the prevalence is between 7 and 11%. The exacerbation of asthma by second-hand tobacco smoke is well documented, but as smoking tobacco has declined, smoking wacky weed has increased. What effect has this second-hand smoke had on “the children?”

Asthma is a significant disease; among children, the prevalence is between 7 and 11%. The exacerbation of asthma by second-hand tobacco smoke is well documented, but as smoking tobacco has declined, smoking wacky weed has increased. What effect has this second-hand smoke had on “the children?”

Climate Change: "We Have Met The Enemy, And He Is Us."

By Fred Lipfert, PhD — Jan 18, 2023
Climate change may now be the most cogent global environmental issue of the day. Emissions of greenhouse gases, notably CO2, continue apace, despite angst among environmental groups, and various worldwide governmental goals and pledges. Here I estimate the longitudinal relationships of global mean temperature with population, CO2 emissions, ambient CO2, and gross domestic product (GDP) using 50 years of published annual data.

Climate change may now be the most cogent global environmental issue of the day. Emissions of greenhouse gases, notably CO2, continue apace, despite angst among environmental groups, and various worldwide governmental goals and pledges. Here I estimate the longitudinal relationships of global mean temperature with population, CO2 emissions, ambient CO2, and gross domestic product (GDP) using 50 years of published annual data.

A Real-Life Hallmark Movie Moment

By Henry I. Miller, MS, MD — Jan 17, 2023
As a memorial to his beloved dog, a retired home builder began making and giving away dog ramps. My elderly Bedlington terrier was one of the beneficiaries.

As a memorial to his beloved dog, a retired home builder began making and giving away dog ramps. My elderly Bedlington terrier was one of the beneficiaries.

It is Time for Policymakers to Protect Patients from Predatory Practices of Insurers and PBMs

By Robert Popovian — Jan 17, 2023
Policymakers often talk about protecting patients against the predatory practices of insurers and PBMs. It is about time for state and federal legislators to support such legislations to ensure that ONLY patients benefit from such patient assistance programs and to stop PBM and insurers from profiteering on the backs of patients.

Policymakers often talk about protecting patients against the predatory practices of insurers and PBMs. It is about time for state and federal legislators to support such legislations to ensure that ONLY patients benefit from such patient assistance programs and to stop PBM and insurers from profiteering on the backs of patients.

Cooking with Gas

By Chuck Dinerstein, MD, MBA — Jan 17, 2023
The Consumer Products Safety Commission (CPSC) recently concluded that gas stoves have polluted our indoor spaces. So polluted that “more than 12% of current childhood asthma cases in the US can be attributed to gas stove use.” Could that be true? Only if you believe in Mathmagic.

The Consumer Products Safety Commission (CPSC) recently concluded that gas stoves have polluted our indoor spaces. So polluted that “more than 12% of current childhood asthma cases in the US can be attributed to gas stove use.” Could that be true? Only if you believe in Mathmagic.

Filtered or Unfiltered Water

By Susan Goldhaber MPH — Jan 17, 2023
If you haven’t already given up on your New Year’s resolutions – clean out sock drawer, organize closets, exercise more, there is one resolution if you have a home water filtration system you need to add and make sure to keep – change the filter every few months (or as recommended by the manufacturer). In this article, I will explain why.

If you haven’t already given up on your New Year’s resolutions – clean out sock drawer, organize closets, exercise more, there is one resolution if you have a home water filtration system you need to add and make sure to keep – change the filter every few months (or as recommended by the manufacturer). In this article, I will explain why.

Stanford University’s Fickle Commitment to Science, Part 2

By Henry I. Miller, MS, MD — Jan 17, 2023
Part 1 of this two-part series described the “Stanford University paradox” – the uncritical embrace of politically correct concepts that contradict its reputation as a cutting-edge, science-grounded institution. I described the contrast between the university’s outstanding research and its dubious view of “sustainability,” which includes a commitment to organic farming practices. I elaborate on the latter here, in Part 2.

Part 1 of this two-part series described the “Stanford University paradox” – the uncritical embrace of politically correct concepts that contradict its reputation as a cutting-edge, science-grounded institution. I described the contrast between the university’s outstanding research and its dubious view of “sustainability,” which includes a commitment to organic farming practices. I elaborate on the latter here, in Part 2.

The Fate of Another Antibiotic Biotech - Nabriva

By David Shlaes — Jan 16, 2023
Nabriva, an antibiotic biotech, recently announced that they were winding down its operations. While this is sad, it may not be so much a market failure problem in this particular case.

Nabriva, an antibiotic biotech, recently announced that they were winding down its operations. While this is sad, it may not be so much a market failure problem in this particular case.

Advertising Drugs on Television

By Chuck Dinerstein, MD, MBA — Jan 16, 2023
In 2016, the American viewing public was exposed to 663,000 television commercials for pharmaceuticals. That is a significant “ad spend” by Pharma, which we pay for through increased drug pricing. A new study looks at the therapeutic value of the more heavily advertised drugs. The key concept here is “market differentiation.”

In 2016, the American viewing public was exposed to 663,000 television commercials for pharmaceuticals. That is a significant “ad spend” by Pharma, which we pay for through increased drug pricing. A new study looks at the therapeutic value of the more heavily advertised drugs. The key concept here is “market differentiation.”

Another One Bites The Dust: Fluvoxamine Fails As A Covid Treatment Fails. Badly

By Josh Bloom — Jan 16, 2023
Yet another potential Covid treatment has fallen by the wayside. This time it's fluvoxamine, an antidepressant, which showed some promise in minimizing serious disease in small trials. But in a large, randomized trial, it flopped completely. The lesson? You need an antiviral drug to treat a viral infection – not a repurposed drug. These have all failed.

Yet another potential Covid treatment has fallen by the wayside. This time it's fluvoxamine, an antidepressant, which showed some promise in minimizing serious disease in small trials. But in a large, randomized trial, it flopped completely. The lesson? You need an antiviral drug to treat a viral infection – not a repurposed drug. These have all failed.